SseJ Deacylase Activity by Salmonella enterica Serovar Typhimurium Promotes Virulence in Mice

ABSTRACT Salmonella enterica serovar Typhimurium utilizes a type III secretion system (TTSS) encoded on Salmonella pathogenicity island-2 (SPI2) to promote intracellular replication during infection, but little is known about the molecular function of SPI2-translocated effectors and how they contribute to this process. SseJ is a SPI2 TTSS effector protein that is homologous to enzymes called glycerophospholipid-cholesterol acyltransferases and, following translocation, localizes to the Salmonella-containing vacuole and Salmonella-induced filaments. Full virulence requires SseJ, as sseJ null mutants exhibit decreased replication in cultured cells and host tissues. This work demonstrates that SseJ is an enzyme with deacylase activity in vitro and identifies three active-site residues. Catalytic SseJ mutants display wild-type translocation and subcellular localization but fail to complement the virulence defect of an sseJ null mutant. In contrast to the wild type, SseJ catalytic mutants fail to down regulate Salmonella-induced filament formation and fail to restore the sifA null mutant phenotype of loss of phagosomal membrane to sifA sseJ null double mutants, suggesting that wild-type SseJ modifies the vacuolar membrane. This is the first demonstration of an enzymatic activity for a SPI2 effector protein and provides support for the hypothesis that the deacylation of lipids on the Salmonella-containing vacuole membrane is important to bacterial pathogenesis.

[1]  Samuel I. Miller,et al.  Salmonella-Induced Filament Formation Is a Dynamic Phenotype Induced by Rapidly Replicating Salmonella enterica Serovar Typhimurium in Epithelial Cells , 2005, Infection and Immunity.

[2]  B. Finlay,et al.  The related effector proteins SopD and SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence during systemic infection of mice , 2004, Molecular microbiology.

[3]  J. Trowsdale,et al.  Inhibition of cell surface MHC class II expression by Salmonella , 2004, European journal of immunology.

[4]  B. Finlay,et al.  SseK1 and SseK2 Are Novel Translocated Proteins of Salmonella enterica Serovar Typhimurium , 2004, Infection and Immunity.

[5]  M. Hensel,et al.  Effector Proteins Encoded by Salmonella Pathogenicity Island 2 Interfere with the Microtubule Cytoskeleton after Translocation into Host Cells , 2004, Traffic.

[6]  D. Holden,et al.  SseG, a virulence protein that targets Salmonella to the Golgi network , 2003, The EMBO journal.

[7]  B. Finlay,et al.  Salmonella type III effectors PipB and PipB2 are targeted to detergent‐resistant microdomains on internal host cell membranes , 2003, Molecular microbiology.

[8]  Samuel I. Miller,et al.  A Salmonella enterica Serovar Typhimurium Translocated Leucine-Rich Repeat Effector Protein Inhibits NF-κB-Dependent Gene Expression , 2003, Infection and Immunity.

[9]  Samuel I. Miller,et al.  Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton , 2003, Molecular microbiology.

[10]  Samuel I. Miller,et al.  The Salmonella enterica Serovar Typhimurium Translocated Effectors SseJ and SifB Are Targeted to the Salmonella-Containing Vacuole , 2003, Infection and Immunity.

[11]  M. Hensel,et al.  SseF and SseG are translocated effectors of the type III secretion system of Salmonella pathogenicity island 2 that modulate aggregation of endosomal compartments , 2002, Cellular microbiology.

[12]  B. Neumeister,et al.  Characterization of the Gene Encoding the Major Secreted Lysophospholipase A of Legionella pneumophila and Its Role in Detoxification of Lysophosphatidylcholine , 2002, Infection and Immunity.

[13]  C. Beuzón,et al.  Growth and killing of a Salmonella enterica serovar Typhimurium sifA mutant strain in the cytosol of different host cell lines. , 2002, Microbiology.

[14]  B. Finlay,et al.  Disruption of the Salmonella-Containing Vacuole Leads to Increased Replication of Salmonella enterica Serovar Typhimurium in the Cytosol of Epithelial Cells , 2002, Infection and Immunity.

[15]  K. Haldar,et al.  The Salmonella‐containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI‐anchored protein CD55 , 2002, Cellular microbiology.

[16]  B. Finlay,et al.  SifA, a Type III Secreted Effector of Salmonella typhimurium, Directs Salmonella‐Induced Filament (Sif) Formation Along Microtubules , 2002, Traffic.

[17]  M. Hensel,et al.  Salmonella Pathogenicity Island 2 Mediates Protection of Intracellular Salmonella from Reactive Nitrogen Intermediates , 2002, The Journal of experimental medicine.

[18]  Javier Ruiz-Albert,et al.  Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane , 2002, Molecular microbiology.

[19]  R. Hayward,et al.  The Salmonella pathogenicity island 1 secretion system directs cellular cholesterol redistribution during mammalian cell entry and intracellular trafficking , 2002, Cellular microbiology.

[20]  C. Beuzón,et al.  Use of mixed infections with Salmonella strains to study virulence genes and their interactions in vivo. , 2001, Microbes and infection.

[21]  B. Finlay,et al.  Characterization of Salmonella‐Induced Filaments (Sifs) Reveals a Delayed Interaction Between Salmonella‐Containing Vacuoles and Late Endocytic Compartments , 2001, Traffic.

[22]  Samuel I. Miller,et al.  CHAPTER 7 – Molecular Pathogenesis of Salmonellae , 2001 .

[23]  S. Miller,et al.  Salmonella: a model for bacterial pathogenesis. , 2001, Annual review of medicine.

[24]  E. Groisman Principles of bacterial pathogenesis , 2001 .

[25]  J. Galán,et al.  Salmonella interactions with host cells: type III secretion at work. , 2001, Annual review of cell and developmental biology.

[26]  S. Méresse,et al.  Salmonella maintains the integrity of its intracellular vacuole through the action of SifA , 2000, The EMBO journal.

[27]  S. Miller,et al.  A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Hensel,et al.  Salmonella Pathogenicity Island 2 , 2000, Molecular microbiology.

[30]  F. Fang,et al.  Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. , 2000, Science.

[31]  S. Miller,et al.  Salmonella typhimurium leucine‐rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems , 1999, Molecular microbiology.

[32]  C. Hueck,et al.  Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants , 1998, Microbiology and Molecular Biology Reviews.

[33]  B. Finlay,et al.  Identification of a Salmonella virulence gene required for formation of filamentous structures containing lysosomal membrane glycoproteins within epithelial cells , 1996, Molecular microbiology.

[34]  M. Brumlik,et al.  Identification of the catalytic triad of the lipase/acyltransferase from Aeromonas hydrophila , 1996, Journal of bacteriology.

[35]  J. Shea,et al.  Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C Upton,et al.  A new family of lipolytic enzymes? , 1995, Trends in biochemical sciences.

[37]  B. Finlay,et al.  Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. F. Wang,et al.  Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. , 1991, Gene.

[39]  A. Jonas,et al.  Reaction of lecithin cholesterol acyltransferase with water-soluble substrates. , 1989, The Journal of biological chemistry.

[40]  S. Macintyre,et al.  Purification and partial characterization of a bacterial phospholipid: cholesterol acyltransferase. , 1982, The Journal of biological chemistry.

[41]  S. Macintyre,et al.  Presence of glycerophospholipid: cholesterol acyltransferase and phospholipase in culture supernatant of Aeromonas hydrophila , 1978, Journal of bacteriology.